1-7 of 7
Michael Dechant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Recombinant Dimeric IgA Antibodies against the Epidermal Growth Factor Receptor Mediate Effective Tumor Cell Killing

Free
Stefan Lohse, Stefanie Derer, Thomas Beyer, Katja Klausz, Matthias Peipp, Jeanette H. W. Leusen, Jan G. J. van de Winkel, Michael Dechant, Thomas Valerius
Journal: The Journal of Immunology
J Immunol (2011) 186 (6): 3770–3778.
https://doi.org/10.4049/jimmunol.1003082
Published: 15 March 2011
View articletitled, Recombinant Dimeric IgA Antibodies against the Epidermal Growth Factor Receptor Mediate Effective Tumor Cell Killing
Open the PDF for Recombinant Dimeric IgA Antibodies against the Epidermal Growth Factor Receptor Mediate Effective Tumor Cell Killing in another window
Add to Citation Manager for Recombinant Dimeric IgA Antibodies against the Epidermal Growth Factor Receptor Mediate Effective Tumor Cell Killing
Includes: Supplementary data
Journal Articles

A Recombinant Bispecific Single-Chain Fragment Variable Specific for HLA Class II and FcαRI (CD89) Recruits Polymorphonuclear Neutrophils for Efficient Lysis of Malignant B Lymphoid Cells

Free
Yvonne Guettinger, Karin Barbin, Matthias Peipp, Joerg Bruenke, Michael Dechant, Heike Horner, Doreen Thierschmidt, Thomas Valerius, Roland Repp, Georg H. Fey, Bernhard Stockmeyer
Journal: The Journal of Immunology
J Immunol (2010) 184 (3): 1210–1217.
https://doi.org/10.4049/jimmunol.0902033
Published: 30 December 2009
View articletitled, A Recombinant Bispecific Single-Chain Fragment Variable Specific for HLA Class II and FcαRI (CD89) Recruits Polymorphonuclear Neutrophils for Efficient Lysis of Malignant B Lymphoid Cells
Open the PDF for A Recombinant Bispecific Single-Chain Fragment Variable Specific for HLA Class II and FcαRI (CD89) Recruits Polymorphonuclear Neutrophils for Efficient Lysis of Malignant B Lymphoid Cells in another window
Add to Citation Manager for A Recombinant Bispecific Single-Chain Fragment Variable Specific for HLA Class II and FcαRI (CD89) Recruits Polymorphonuclear Neutrophils for Efficient Lysis of Malignant B Lymphoid Cells
Journal Articles

Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage

Free
Tanja Schneider-Merck, Jeroen J. Lammerts van Bueren, Sven Berger, Kai Rossen, Patrick H.C. van Berkel, Stefanie Derer, Thomas Beyer, Stefan Lohse, Wim K. Bleeker, Matthias Peipp, Paul W. H. I. Parren, Jan G. J. van de Winkel, Thomas Valerius, Michael Dechant
Journal: The Journal of Immunology
J Immunol (2010) 184 (1): 512–520.
https://doi.org/10.4049/jimmunol.0900847
Published: 14 December 2009
View articletitled, Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage
Open the PDF for Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage in another window
Add to Citation Manager for Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage
Journal Articles

Tumor Cell Killing Mechanisms of Epidermal Growth Factor Receptor (EGFR) Antibodies Are Not Affected by Lung Cancer-Associated EGFR Kinase Mutations

Free
Matthias Peipp, Tanja Schneider-Merck, Michael Dechant, Thomas Beyer, Jeroen J. Lammerts van Bueren, Wim K. Bleeker, Paul W. H. I. Parren, Jan G. J. van de Winkel, Thomas Valerius
Journal: The Journal of Immunology
J Immunol (2008) 180 (6): 4338–4345.
https://doi.org/10.4049/jimmunol.180.6.4338
Published: 15 March 2008
View articletitled, Tumor Cell Killing Mechanisms of Epidermal Growth Factor Receptor (EGFR) Antibodies Are Not Affected by Lung Cancer-Associated EGFR Kinase Mutations
Open the PDF for Tumor Cell Killing Mechanisms of Epidermal Growth Factor Receptor (EGFR) Antibodies Are Not Affected by Lung Cancer-Associated EGFR Kinase Mutations in another window
Add to Citation Manager for Tumor Cell Killing Mechanisms of Epidermal Growth Factor Receptor (EGFR) Antibodies Are Not Affected by Lung Cancer-Associated EGFR Kinase Mutations
Journal Articles

Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor

Free
Michael Dechant, Thomas Beyer, Tanja Schneider-Merck, Wencke Weisner, Matthias Peipp, Jan G. J. van de Winkel, Thomas Valerius
Journal: The Journal of Immunology
J Immunol (2007) 179 (5): 2936–2943.
https://doi.org/10.4049/jimmunol.179.5.2936
Published: 01 September 2007
View articletitled, Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor
Open the PDF for Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor in another window
Add to Citation Manager for Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor
Journal Articles

Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors

Free
Marielle A. Otten, Esther Rudolph, Michael Dechant, Cornelis W. Tuk, Rogier M. Reijmers, Robert H. J. Beelen, Jan G. J. van de Winkel, Marjolein van Egmond
Journal: The Journal of Immunology
J Immunol (2005) 174 (9): 5472–5480.
https://doi.org/10.4049/jimmunol.174.9.5472
Published: 01 May 2005
View articletitled, Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors
Open the PDF for Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors in another window
Add to Citation Manager for Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors
Includes: Multimedia, Supplementary data
Journal Articles

Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy

Free
Bernhard Stockmeyer, Michael Dechant, Marjolein van Egmond, Alison L. Tutt, Karuna Sundarapandiyan, Robert F. Graziano, Roland Repp, Joachim R. Kalden, Martin Gramatzki, Martin J. Glennie, Jan G. J. van de Winkel, Thomas Valerius
Journal: The Journal of Immunology
J Immunol (2000) 165 (10): 5954–5961.
https://doi.org/10.4049/jimmunol.165.10.5954
Published: 15 November 2000
View articletitled, Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy
Open the PDF for Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy in another window
Add to Citation Manager for Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy